2023-03-012024-02-292024-02-29false07539017LEFT EYE BLIND PRODUCTIONS LTD2024-10-21iso4217:GBPxbrli:pure075390172023-03-01075390172024-02-29075390172023-03-012024-02-29075390172022-03-01075390172023-02-28075390172022-03-012023-02-2807539017bus:SmallEntities2023-03-012024-02-2907539017bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2907539017bus:AbridgedAccounts2023-03-012024-02-2907539017bus:PrivateLimitedCompanyLtd2023-03-012024-02-2907539017core:WithinOneYear2024-02-2907539017core:AfterOneYear2024-02-2907539017core:WithinOneYear2023-02-2807539017core:AfterOneYear2023-02-2807539017core:ShareCapital2024-02-2907539017core:SharePremium2024-02-2907539017core:RevaluationReserve2024-02-2907539017core:OtherReservesSubtotal2024-02-2907539017core:RetainedEarningsAccumulatedLosses2024-02-2907539017core:ShareCapital2023-02-2807539017core:SharePremium2023-02-2807539017core:RevaluationReserve2023-02-2807539017core:OtherReservesSubtotal2023-02-2807539017core:RetainedEarningsAccumulatedLosses2023-02-2807539017core:LandBuildings2024-02-2907539017core:PlantMachinery2024-02-2907539017core:Vehicles2024-02-2907539017core:FurnitureFittings2024-02-2907539017core:OfficeEquipment2024-02-2907539017core:NetGoodwill2024-02-2907539017core:IntangibleAssetsOtherThanGoodwill2024-02-2907539017core:ListedExchangeTraded2024-02-2907539017core:UnlistedNon-exchangeTraded2024-02-2907539017core:LandBuildings2023-02-2807539017core:PlantMachinery2023-02-2807539017core:Vehicles2023-02-2807539017core:FurnitureFittings2023-02-2807539017core:OfficeEquipment2023-02-2807539017core:NetGoodwill2023-02-2807539017core:IntangibleAssetsOtherThanGoodwill2023-02-2807539017core:ListedExchangeTraded2023-02-2807539017core:UnlistedNon-exchangeTraded2023-02-2807539017core:LandBuildings2023-03-012024-02-2907539017core:PlantMachinery2023-03-012024-02-2907539017core:Vehicles2023-03-012024-02-2907539017core:FurnitureFittings2023-03-012024-02-2907539017core:OfficeEquipment2023-03-012024-02-2907539017core:NetGoodwill2023-03-012024-02-2907539017core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2907539017core:ListedExchangeTraded2023-03-012024-02-2907539017core:UnlistedNon-exchangeTraded2023-03-012024-02-2907539017core:MoreThanFiveYears2023-03-012024-02-2907539017core:Non-currentFinancialInstruments2024-02-2907539017core:Non-currentFinancialInstruments2023-02-2807539017dpl:CostSales2023-03-012024-02-2907539017dpl:DistributionCosts2023-03-012024-02-2907539017core:LandBuildings2023-03-012024-02-2907539017core:PlantMachinery2023-03-012024-02-2907539017core:Vehicles2023-03-012024-02-2907539017core:FurnitureFittings2023-03-012024-02-2907539017core:OfficeEquipment2023-03-012024-02-2907539017dpl:AdministrativeExpenses2023-03-012024-02-2907539017core:NetGoodwill2023-03-012024-02-2907539017core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2907539017dpl:GroupUndertakings2023-03-012024-02-2907539017dpl:ParticipatingInterests2023-03-012024-02-2907539017dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2907539017core:ListedExchangeTraded2023-03-012024-02-2907539017dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2907539017core:UnlistedNon-exchangeTraded2023-03-012024-02-2907539017dpl:CostSales2022-03-012023-02-2807539017dpl:DistributionCosts2022-03-012023-02-2807539017core:LandBuildings2022-03-012023-02-2807539017core:PlantMachinery2022-03-012023-02-2807539017core:Vehicles2022-03-012023-02-2807539017core:FurnitureFittings2022-03-012023-02-2807539017core:OfficeEquipment2022-03-012023-02-2807539017dpl:AdministrativeExpenses2022-03-012023-02-2807539017core:NetGoodwill2022-03-012023-02-2807539017core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2807539017dpl:GroupUndertakings2022-03-012023-02-2807539017dpl:ParticipatingInterests2022-03-012023-02-2807539017dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2807539017core:ListedExchangeTraded2022-03-012023-02-2807539017dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2807539017core:UnlistedNon-exchangeTraded2022-03-012023-02-2807539017core:NetGoodwill2024-02-2907539017core:IntangibleAssetsOtherThanGoodwill2024-02-2907539017core:LandBuildings2024-02-2907539017core:PlantMachinery2024-02-2907539017core:Vehicles2024-02-2907539017core:FurnitureFittings2024-02-2907539017core:OfficeEquipment2024-02-2907539017core:AfterOneYear2024-02-2907539017core:WithinOneYear2024-02-2907539017core:ListedExchangeTraded2024-02-2907539017core:UnlistedNon-exchangeTraded2024-02-2907539017core:ShareCapital2024-02-2907539017core:SharePremium2024-02-2907539017core:RevaluationReserve2024-02-2907539017core:OtherReservesSubtotal2024-02-2907539017core:RetainedEarningsAccumulatedLosses2024-02-2907539017core:NetGoodwill2023-02-2807539017core:IntangibleAssetsOtherThanGoodwill2023-02-2807539017core:LandBuildings2023-02-2807539017core:PlantMachinery2023-02-2807539017core:Vehicles2023-02-2807539017core:FurnitureFittings2023-02-2807539017core:OfficeEquipment2023-02-2807539017core:AfterOneYear2023-02-2807539017core:WithinOneYear2023-02-2807539017core:ListedExchangeTraded2023-02-2807539017core:UnlistedNon-exchangeTraded2023-02-2807539017core:ShareCapital2023-02-2807539017core:SharePremium2023-02-2807539017core:RevaluationReserve2023-02-2807539017core:OtherReservesSubtotal2023-02-2807539017core:RetainedEarningsAccumulatedLosses2023-02-2807539017core:NetGoodwill2022-03-0107539017core:IntangibleAssetsOtherThanGoodwill2022-03-0107539017core:LandBuildings2022-03-0107539017core:PlantMachinery2022-03-0107539017core:Vehicles2022-03-0107539017core:FurnitureFittings2022-03-0107539017core:OfficeEquipment2022-03-0107539017core:AfterOneYear2022-03-0107539017core:WithinOneYear2022-03-0107539017core:ListedExchangeTraded2022-03-0107539017core:UnlistedNon-exchangeTraded2022-03-0107539017core:ShareCapital2022-03-0107539017core:SharePremium2022-03-0107539017core:RevaluationReserve2022-03-0107539017core:OtherReservesSubtotal2022-03-0107539017core:RetainedEarningsAccumulatedLosses2022-03-0107539017core:AfterOneYear2023-03-012024-02-2907539017core:WithinOneYear2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2907539017core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2907539017core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2907539017core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2907539017core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2907539017core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2907539017core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2907539017core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2907539017core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2907539017core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2907539017core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2807539017core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2807539017core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2807539017core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2807539017core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2807539017core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2807539017core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2807539017core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2807539017core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2807539017bus:Director12023-03-012024-02-2907539017bus:Director22023-03-012024-02-29

LEFT EYE BLIND PRODUCTIONS LTD

Registered Number
07539017
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

LEFT EYE BLIND PRODUCTIONS LTD
Company Information
for the year from 1 March 2023 to 29 February 2024

Directors

MAUDE, Matthew Christopher
WILLAN, Clare Alison

Registered Address

Third Floor
10 South Parade
Leeds
LS1 5QS

Registered Number

07539017 (England and Wales)
LEFT EYE BLIND PRODUCTIONS LTD
Statement of Financial Position
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets314,57615,714
Investments45050
14,62615,764
Current assets
Debtors55,22813,702
Cash at bank and on hand44,96257,584
50,19071,286
Creditors amounts falling due within one year6(17,120)(13,614)
Net current assets (liabilities)33,07057,672
Total assets less current liabilities47,69673,436
Provisions for liabilities(2,769)(2,986)
Net assets44,92770,450
Capital and reserves
Called up share capital100100
Profit and loss account44,82770,350
Shareholders' funds44,92770,450
The financial statements were approved and authorised for issue by the Board of Directors on 21 October 2024, and are signed on its behalf by:
MAUDE, Matthew Christopher
Director
Registered Company No. 07539017
LEFT EYE BLIND PRODUCTIONS LTD
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to the Income Statement
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Research and development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight line basis over their useful economic lives, which range from 3 to 6 years. If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Plant and machinery3
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the Income Statement.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete). At each date of Statement of Financial Position, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Income Statement. Work in progress is valued on the basis of direct costs plus attributable overheads based on normal level of activity. Provision is made for any foreseeable losses where appropriate. No element of profit is included in the valuation of work in progress.
Financial instruments
The company enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares. Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method. Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Government grants or assistance
Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income. Grants of a revenue nature are recognised in the Income Statement in the same period as the related expenditure.
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 March 2349,912
Additions6,662
At 29 February 2456,574
Depreciation and impairment
At 01 March 2334,198
Charge for year7,800
At 29 February 2441,998
Net book value
At 29 February 2414,576
At 28 February 2315,714
4.Fixed asset investments

Total

£
Cost or valuation
At 01 March 2350
At 29 February 2450
Net book value
At 29 February 2450
At 28 February 2350
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables3,4589,744
Other debtors1,7703,958
Total5,22813,702
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables123500
Taxation and social security7,078757
Other creditors6,0358,719
Accrued liabilities and deferred income3,8843,638
Total17,12013,614